In a paper published March 18 in the journal Nature, researchers at the Johns Hopkins University School of Medicine found that sulforaphane (SFN) showed resistance in both in vitro and animal experiments activity of COVID-19 and seasonal coronavirus HCoV-OC43 to suppress the replication of Coronavirus.
Several studies have shown that SFN, a glucosinolate in cruciferous vegetables, has significant antioxidant and anti-inflammatory effects.
The results of the study revealed that SFN limited the in vitro replication of the coronavirus SARS-CoV-2, including Delta, Omicron, and the seasonal coronavirus HCoV-OC43.
The researchers believe that SFN should be explored as a potential drug to prevent or treat coronavirus infections.